Management

H. Trent Spencer, Ph.D.
Dr.Spencer received his Ph.D. in Biochemistry from Creighton School of Medicine in Omaha. His postdoctoral studies at St. Jude Children's Research Hospital focused on drug resistance gene therapy and in vivo selection of genetically-modified cells. He is currently an Associate Professor within the Aflac Cancer Center and Blood Disorders Service at Emory University. His previous affiliations include an Assistant Professor in the South Carolina Cancer Center/Department of Biological Sciences, University of South Carolina and Assistant Director of the Molecular Genetics Program. He has headed a well funded gene therapy laboratory for over 10 years. His research interests continue to be the development of gene therapy applications for the treatment of cancer and inherited diseases.
e-mail: ![HTspencer [at] expression therapeutics .com](/images/htspencer-email.jpg)

Christopher B. Doering, Ph.D.
Dr. Doering received his Ph.D. in Genetics and Molecular Biology from Emory University and pursued post-doctoral studies investigating the regulatory aspects of factor VIII biosynthesis. Currently, he is an Assistant Professor within the Department of Pediatrics, Aflac Cancer Center and Blood Disorders Service at Emory University School of Medicine. Dr. Doering has more than 15 years of experience studying gene and protein expression as it relates to common genetic diseases and currently, his laboratory continues to pursue this line of research.
e-mail: ![cdoering [at] expression therapeutics .com](/images/cdoering-email.jpg)

John S. (Pete) Lollar, III, M.D.
Dr. Lollar received his medical degree at St. Louis University and underwent residency and fellowship training in Internal Medicine and Hematology & Oncology at the University of Iowa and the Mayo Clinic. He has conducted research on the structure and function of the factor VIII - von Willebrand factor complex, the assembly of the intrinsic pathway factor X activation complex, the immune response to factor VIII and the biosynthesis of factor VIII. He currently is Hemophilia of Georgia Professor of Pediatrics at Emory University.
e-mail: ![Jlollar [at] expression therapeutics .com](/images/jlollar-email.jpg)

Mohan Rao, Ph.D.
Dr. Rao is a Managing Director at Navigant Economics and an Adjunct Professor in the Department of Industrial Engineering and Management Sciences at Northwestern University. He has expertise with the economics of factor VIII. Dr. Rao has a Ph.D. from the University of Colorado and a pre-doctoral fellowship from Harvard University. Dr. Rao serves on the Board of Directors of the Children’s Memorial Hospital in Chicago, on the Board of Trustees of the Rotary/One Foundation, and is a member of the Economic Club of Chicago.
e-mail: ![Mrao [at] expression therapeutics .com](/images/mrao-email.jpg)
